Literature DB >> 21160842

Extent of surgical resections for intraductal papillary mucinous neoplasms.

Stefano Crippa1, Stefano Partelli, Massimo Falconi.   

Abstract

Intraductal papillary mucinous neoplasms (IPMNs) can involve the main pancreatic duct (MD-IPMNs) or its secondary branches (BD-IPMNs) in a segmental of multifocal/diffuse fashion. Growing evidence indicates that BD-IPMNs are less likely to harbour cancer and in selected cases these lesions can be managed non operatively. For surgery, clarification is required on: (1) when to resect an IPMN; (2) which type of resection should be performed; and (3) how much pancreas should be resected. In recent years parenchyma-sparing resections as well as laparoscopic procedures have being performed more frequently by pancreatic surgeons in order to decrease the rate of postoperative pancreatic insufficiency and to minimize the surgical impact of these operations. However, oncological radicality is of paramount importance, and extended resections up to total pancreatectomy may be necessary in the setting of IPMNs. In this article the type and extension of surgical resections in patients with MD-IPMNs and BD-IPMNs are analyzed, evaluating perioperative and long-term outcomes. The role of standard and parenchyma-sparing resections is discussed as well as different strategies in the case of multifocal neoplasms.

Entities:  

Keywords:  Diabetes; Exocrine insufficiency; Follow-up; Intraductal papillary mucinous neoplasms; Left pancreatectomy; Pancreaticoduodenectomy; Parenchyma-sparing resections; Total pancreatectomy; Transection margin

Year:  2010        PMID: 21160842      PMCID: PMC2999200          DOI: 10.4240/wjgs.v2.i10.347

Source DB:  PubMed          Journal:  World J Gastrointest Surg


  47 in total

1.  Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Suresh T Chari; Dhiraj Yadav; Thomas C Smyrk; Eugene P DiMagno; Laurence J Miller; Massimo Raimondo; Jonathan E Clain; Ian A Norton; Randall K Pearson; Bret T Petersen; Maurits J Wiersema; Michael B Farnell; Michael G Sarr
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

2.  Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients.

Authors:  Carlos Fernández-del Castillo; Javier Targarona; Sarah P Thayer; David W Rattner; William R Brugge; Andrew L Warshaw
Journal:  Arch Surg       Date:  2003-04

3.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04

4.  Distal pancreatectomy: indications and outcomes in 235 patients.

Authors:  K D Lillemoe; S Kaushal; J L Cameron; T A Sohn; H A Pitt; C J Yeo
Journal:  Ann Surg       Date:  1999-05       Impact factor: 12.969

Review 5.  Exocrine and endocrine pancreatic insufficiency after pancreatic surgery.

Authors:  Stefan Kahl; Peter Malfertheiner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-10       Impact factor: 3.043

6.  Middle segmental pancreatic resection: An option to treat benign pancreatic body lesions.

Authors:  Michael W Müller; Helmut Friess; Jörg Kleeff; Ulf Hinz; Moritz N Wente; Daniel Paramythiotis; Pascal O Berberat; Güralp O Ceyhan; Markus W Büchler
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

7.  Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma.

Authors:  C Max Schmidt; Jeffrey Glant; Jordan M Winter; Jason Kennard; Jennifer Dixon; Qianqian Zhao; Thomas J Howard; James A Madura; Atilla Nakeeb; Henry A Pitt; John L Cameron; Charles J Yeo; Keith D Lillemoe
Journal:  Surgery       Date:  2007-10       Impact factor: 3.982

8.  Laparoscopic distal pancreatectomy: results on a consecutive series of 58 patients.

Authors:  Gianluigi Melotti; Giovanni Butturini; Micaela Piccoli; Luca Casetti; Claudio Bassi; Barbara Mullineris; Maria Grazia Lazzaretti; Paolo Pederzoli
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

9.  Diabetic control after total pancreatectomy.

Authors:  P Jethwa; M Sodergren; A Lala; J Webber; J A C Buckels; S R Bramhall; D F Mirza
Journal:  Dig Liver Dis       Date:  2006-03-09       Impact factor: 4.088

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  13 in total

1.  Intraductal papillary mucinous neoplasm: Coming of age.

Authors:  Charles M Vollmer; Elijah Dixon
Journal:  World J Gastrointest Surg       Date:  2010-10-27

Review 2.  IPMN: surgical treatment.

Authors:  Reto M Käppeli; Sascha A Müller; Bianka Hummel; Christina Kruse; Philip Müller; Jürgen Fornaro; Alexander Wilhelm; Marcel Zadnikar; Bruno M Schmied; Ignazio Tarantino
Journal:  Langenbecks Arch Surg       Date:  2013-09-03       Impact factor: 3.445

Review 3.  [Pathology and classification of intraductal papillary mucinous neoplasms of the pancreas].

Authors:  A M Schlitter; I Esposito
Journal:  Chirurg       Date:  2012-02       Impact factor: 0.955

Review 4.  Surgical Management of Pancreatic Cysts: A Shifting Paradigm Toward Selective Resection.

Authors:  Jon M Gerry; George A Poultsides
Journal:  Dig Dis Sci       Date:  2017-04-18       Impact factor: 3.199

5.  Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.

Authors:  Thula Cannon Walter; Ingo G Steffen; Lars H Stelter; Martin H Maurer; Marcus Bahra; Wladimir Faber; Fritz Klein; Hendrik Bläker; Bernd Hamm; Timm Denecke; Christian Grieser
Journal:  Eur Radiol       Date:  2014-11-30       Impact factor: 5.315

6.  Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.

Authors:  Andrew H Nguyen; Paul A Toste; James J Farrell; Barbara M Clerkin; Jennifer Williams; V Raman Muthusamy; Rabindra R Watson; James S Tomlinson; O Joe Hines; Howard A Reber; Timothy R Donahue
Journal:  J Gastrointest Surg       Date:  2014-11-06       Impact factor: 3.452

7.  Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm.

Authors:  Jacob R Miller; Juliana E Meyer; Joshua A Waters; Mohammad Al-Haddad; John Dewitt; Stuart Sherman; Keith D Lillemoe; C Max Schmidt
Journal:  HPB (Oxford)       Date:  2011-09-09       Impact factor: 3.647

Review 8.  Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current Perspectives.

Authors:  Ersin Gürkan Dumlu; Derya Karakoç; Arif Özdemir
Journal:  Int Surg       Date:  2015-06

Review 9.  Endoscopic ultrasound in the diagnosis of pancreatic intraductal papillary mucinous neoplasms.

Authors:  Alkiviadis Efthymiou; Thrasyvoulos Podas; Emmanouil Zacharakis
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

Review 10.  Laparoscopic distal pancreatectomy: up-to-date and literature review.

Authors:  Maurizio Iacobone; Marilisa Citton; Donato Nitti
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.